Immunoassay Market - Market Size, Sustainable Insights and Growth Report 2024-2031

Immunoassay Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Immunoassay Market&nbsp;Product Size, Share &amp; Trends Analysis Report By Product Type, By Technology, By Specimen, By Application, By End User, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
The global immunoassay market reached US$ 34.6 billion in 2023 and is expected to reach US$ 59.2 billion by 2031, growing at a CAGR of 7.1% during the forecast period 2024-2031.
</blockquote>

Immunoassay is a bioanalytical technique that uses antigen-antibody&nbsp;affinity to differentiate and measure molecules of interest in biological samples. Immunoassays are laboratory procedures that can identify particular compounds quickly and precisely.&nbsp;

Immunoassays are widely used in various fields, including clinical diagnostics, drug discovery, and food testing, to identify and measure the presence of specific substances in a sample.&nbsp;

The market is driven by factors such as technological advancements in immunoassay instruments,&nbsp; rising prevalence of chronic &amp; infectious diseases, and increasing demand for point-of-care diagnostics.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			7.1%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size&nbsp;
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product Type, Technology, Specimen, Application, and End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Launches, Growth Strategies, Revenue Analysis, Porter&#39;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report - <a href="https://www.datamintelligence.com/download-sample/immunoassay-market" target="_blank">Request for Sample</a>

<h2>&nbsp;</h2>

<h3>Market Dynamics: Drivers</h3>

Technological Advancements in Immunoassay Instruments

The demand for the global immunoassay market is driven by multiple factors. Key factors driving the market are the technological advancements in the immunoassay instruments owing to the&nbsp;capability of identifying and measuring particular molecules present in biological samples, immunoassay tools are essential to medical diagnostic procedures.&nbsp;

Antibodies, antigens, proteins, hormones, or medications are examples of these compounds. Due to the growing need in healthcare for quick and precise diagnostic tools, the immunoassay industry has grown significantly and witnessed technical developments over the years.&nbsp;

Moreover, key players in the industry launch technological systems in the immunoassay market help to drive this market growth. For instance, in July 2023-&nbsp;Siemens Healthineers&nbsp;introduced the Atellica CI Analyzer for clinical chemistry and immunoassay testing.

Also, in August 2023- Shine i8000/9000, Fapon&#39;s newest chemiluminescence immunoassay system, was introduced at the 2023 Clinical Lab Expo and Meeting of the&nbsp;American Association of Clinical Chemistry&nbsp;(AACC). The fully automated, high-speed analyzer has an incredibly high throughput of 900 tests per hour and an integrated, compact design with consistent performance.

Similarly in November 2022, Gethin Biotech launched the new MAGICAL 6000 chemiluminescence immunoassay Analyzer at MEDICA. It is a compact and innovative chemiluminescence immunoassay analyzer that is ideal for mid to high-workflow laboratories that require a one-step chemiluminescence solution. The instrument is highly productive and compact, allowing for fully automated operation and the fastest testing speed of any device of its size.

<h3>Restraints</h3>

Factors such as the high cost of instruments and reagents, complex assay procedures, the stringent regulatory framework for the approval of immunoassays, and limited reimbursement policies, are expected to hamper the market.

<h3>Segment Analysis</h3>

The global immunoassay market is segmented based on product type, technology, specimen, application, end-user, and region.

The ELISA&nbsp; segment accounted for approximately 45.1% of the&nbsp; global immunoassay market share

The ELISA segment is expected to hold the largest market share over the forecast period. ELISA is an immunological assay commonly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Some examples include diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum.

In addition, major players in the industry&#39;s innovative new launches drive this market growth. For instance,&nbsp; in February 2023, Charles River Laboratories International, Inc. announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics.

Also, in September 2022, Neogen launched an immunoassay (Veratox VIP) to detect cashew allergens. The Veratox VIP for Cashew allergen test is the second in Neogen&#39;s Veratox VIP series of enhanced quantitative enzyme-linked immunoassay (ELISA) products. It has a high level of specificity to deficient levels of cashew protein.

<h3>Geographical Analysis</h3>

North America accounted for approximately 41.3% of the global immunoassay&nbsp; market share&nbsp;

North America region is expected to hold the largest market share over the forecast period. The rise in demand for diagnostics related to chronic diseases and the availability of technologically advanced diagnostic techniques are expected to propel market growth over the forecast period.&nbsp;

Furthermore, in the U.S., there were 55.7 million people aged over 65 years in 2022 (~17% of the population in the country). Nearly 25% of this senior population suffers from cancer of which 30% are obese, creating an opportunity for local market players to boost their sales of diagnostic products for cancer, cardiology, endocrinology, infectious diseases, and other tests.

Moreover, key players in the industry launch new products, and mergers&nbsp; &amp; acquisitions, would drive this market growth. For instance, in April 2022, GeneProof, a prominent molecular diagnostics firm based in Brno, Czech Republic, merged with American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company.&nbsp;

The merger made them a global market leader in diagnostic products with extensive capabilities covering innovative immunoassay testing kits, real-time PCR testing products, and automated laboratory instrumentation systems.

Also, in February 2022, Agilent Technologies, Inc. introduced Dako SARS-CoV-2 lgG linked immunosorbent assay in the U.S. with plans to launch in other regions, such as Canada, Europe, Latin America, and some parts of Asia Pacific shortly.

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic significantly impacted the global Immunoassay market. The sudden increase in COVID-19 cases increased efforts in R&amp;D in the diagnostics process aided by government funding. The increasing number of COVID-19 instances in 2020 and 2021 fueled the demand for immunoassay kits. The government is working on expanding the market for COVID-19 diagnostics to prevent further disease spread, vaccine supply, and a rise in demand for timely diagnostics.&nbsp;

The emphasis on critical patients has also shifted to developing time-efficient and accurate COVID-19 diagnostic kits. For instance, the FDA approved approximately 88 antibody-based and 256 molecular tests, totaling over 350 diagnostic test kits in 2021.

<h3>Market Segmentation</h3>

By Product Type

<ul>
	<li>Reagents &amp; kits</li>
</ul>

<ul>
	<li>ELISA Reagents &amp; Kits &nbsp;&nbsp;&nbsp;</li>
	<li>Rapid Test Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
	<li>ELISPOT Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
	<li>Western Blot Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;</li>
	<li>Other Reagents &amp; Kits&nbsp;&nbsp;</li>
</ul>

<ul>
	<li>Analyzers&nbsp;</li>
</ul>

<ul>
	<li>Open-ended Systems</li>
	<li>&nbsp;Closed-ended Systems</li>
</ul>

<ul>
	<li>Software &amp; Services</li>
</ul>

By Technology

<ul>
	<li>Radioimmunoassay (RIA)&nbsp;&nbsp;&nbsp;</li>
	<li>&nbsp;Enzyme Immunoassay (EIA)</li>
</ul>

<ul>
	<li>&nbsp;Fluorescence Immunoassays (FIA)</li>
	<li>&nbsp;Chemiluminescence Immunoassays (CLIA)</li>
</ul>

<ul>
	<li>&nbsp;Rapid Assays</li>
	<li>Others</li>
</ul>

By Specimen

<ul>
	<li>Blood</li>
	<li>Saliva</li>
	<li>Urine</li>
	<li>&nbsp;Other Specimens</li>
</ul>

By Application&nbsp;

<ul>
	<li>Therapeutic Drug Monitoring</li>
	<li>&nbsp;Drug Discovery</li>
	<li>Disease Diagnosis&nbsp;</li>
</ul>

<ul>
	<li>Infectious Disease</li>
	<li>&nbsp;Cancer&nbsp;</li>
	<li>Endocrinology&nbsp;</li>
	<li>Autoimmune Disorders</li>
	<li>Cardiology</li>
	<li>Hematology</li>
	<li>Clinical Chemistry</li>
</ul>

<ul>
	<li>Others</li>
</ul>

By End-Users

<ul>
	<li>Hospitals&nbsp;</li>
	<li>Blood Banks</li>
	<li>Clinical Laboratories</li>
	<li>Pharmaceutical and Biotech Companies</li>
	<li>Academic Research Centers</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America</li>
</ul>

<ul>
	<li>U.S.</li>
	<li>Canada</li>
	<li>Mexico</li>
</ul>

<ul>
	<li>Europe</li>
</ul>

<ul>
	<li>Germany</li>
	<li>U.K.</li>
	<li>France</li>
	<li>Spain</li>
	<li>Italy</li>
	<li>Rest of Europe</li>
</ul>

<ul>
	<li>South America</li>
</ul>

<ul>
	<li>Brazil</li>
	<li>Argentina</li>
	<li>Rest of South America</li>
</ul>

<ul>
	<li>Asia-Pacific</li>
</ul>

<ul>
	<li>China</li>
	<li>India</li>
	<li>Japan</li>
	<li>South Korea</li>
	<li>Rest of Asia-Pacific</li>
</ul>

<ul>
	<li>Middle East and Africa</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the immunoassay market include Abbott, Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, bioM&eacute;rieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., BD, Thermo Fisher Scientific Inc., Merck KGaA among others.

<h3>Key Developments</h3>

<ul>
	<li>In July 2023, Sysmex Corporation introduced a novel fully automated, and high-speed chemiluminescence immunoassay system at the 2023 AACC exhibition.</li>
	<li>&nbsp;In July 2023, SEKISUI Diagnostics, introduced the OSOM COVID-19 Antigen Home Test, a lateral flow immunoassay for diagnosis of SARS-CoV-2 virus.</li>
	<li>In March 2023,&nbsp;F. Hoffmann-La Roche Ltd.&nbsp;collaborated with Eli Lily and Company to support the development of Roche&rsquo;s Elecsys Amyloid Plasma Panel (EAPP).</li>
	<li>In February 2023, bioM&eacute;rieux company received 510(k) clearance and the CLIA waiver for their BIOFIRE SPOTFIRE system and BIOFIRE SPOTFIRE respiratory panel.</li>
	<li>In February 2022, bioM&eacute;rieux launched VIDAS KUBE, a next-generation system for automated immunoassay testing. At the beginning of 2023, it was planned in selected countries and the rest of the world, extending gradually as of Q2.</li>
	<li>&nbsp;In April 2022, The Simple Plex HEK 293 HCP 3G assay for automated process impurity detection on the Ella immunoassay platform was launched by Bio-Techne Corporation and Cygnus Technologies, a division of Maravai LifeSciences. In Gene and Cell Therapy applications, purifying viral particles to reduce host cell protein (HCP) contamination is an important part of the viral production workflow. Impurity clearance is performed according to regulatory criteria to guarantee HCP and accurate quantification throughout process phases is required.</li>
	<li>In November 2022, LumiraDx launched a rapid microfluidic immunoassay HbA1c test in Europe, parts of the Middle East, Asia, Latin America, and Africa.</li>
	<li>&nbsp;In February 2022, NOVEOS Immunoassay Analyzer gained additional FDA 510(k) clearance from Hycor Biomedical Inc., a medical device firm that makes and supplies in-vitro diagnostic equipment. The NOVEOS Immunoassay Analyzer is a chemiluminescent immunoassay analyzer that can diagnose allergies. It&#39;s made to assist with analyte concentration measurements in human samples.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global immunoassay market segmentation based on product type, technology, specimen, application, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development</li>
	<li>Excel data sheet with numerous data points of global immunoassay market level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping is available in excel consisting of key products of all the major players.</li>
</ul>

The global immunoassay market report would provide approximately 78 tables, 94 figures, and 181 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Technology</li>
		<li>Snippet by Specimen</li>
		<li>Snippet by Application</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Technological Advancements in Immunoassay Instruments</li>
				<li>Rising Prevalence of Chronic &amp; Infectious Diseases&nbsp;</li>
				<li>Increasing Demand for Point-of-Care Diagnostics</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>The High Cost of Instruments &amp; Reagents</li>
				<li>Complex Assay Procedures</li>
			</ol>
			</li>
			<li>&nbsp;Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>PESTEL Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During the Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Reagents &amp; kits*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
			<li>Portable Immunoassay</li>
			<li>ELISA Reagents &amp; Kits &nbsp;&nbsp;&nbsp;</li>
			<li>Rapid Test Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
			<li>ELISPOT Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
			<li>Western Blot Reagents &amp; Kits&nbsp;&nbsp;&nbsp;&nbsp;</li>
			<li>Other Reagents &amp; Kits&nbsp;&nbsp;</li>
		</ol>
		</li>
		<li>Analyzers&nbsp;
		<ol>
			<li>Open-ended Systems</li>
			<li>&nbsp;Closed-ended Systems</li>
		</ol>
		</li>
		<li>Software &amp; Services</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>Radioimmunoassay (RIA) *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Enzyme Immunoassay (EIA)</li>
		<li>&nbsp;Fluorescence Immunoassays (FIA)</li>
		<li>&nbsp;Chemiluminescence Immunoassays (CLIA)</li>
		<li>&nbsp;Rapid Assays</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Specimen</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Attractiveness Index, By Specimen</li>
		</ol>
		</li>
		<li>Blood*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Saliva</li>
		<li>Urine</li>
		<li>Other Specimen</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Therapeutic Drug Monitoring *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Drug Discovery</li>
		<li>Disease Diagnosis&nbsp;
		<ol>
			<li>Infectious Disease</li>
			<li>&nbsp;Cancer&nbsp;</li>
			<li>Endocrinology&nbsp;</li>
			<li>Autoimmune Disorders</li>
			<li>Cardiology</li>
			<li>Hematology</li>
			<li>Clinical Chemistry</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Blood Banks</li>
		<li>Clinical Laboratories</li>
		<li>Pharmaceutical and Biotech Companies</li>
		<li>Academic Research Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>&nbsp;Abbott *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio &amp; Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Beckman Coulter, Inc</li>
		<li>F. Hoffmann-La Roche Ltd</li>
		<li>Siemens Healthcare Private Limited</li>
		<li>bioM&eacute;rieux SA</li>
		<li>Bio-Rad Laboratories, Inc</li>
		<li>DiaSorin S.p.A.</li>
		<li>BD</li>
		<li>Thermo Fisher Scientific Inc</li>
		<li>Merck KGaA&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Immunoassay Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Immunoassay Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Immunoassay Market Value, By Specimen, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Immunoassay Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Immunoassay Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Immunoassay Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Immunoassay Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 9 Global Immunoassay Market Value, By Technology, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 11 Global Immunoassay Market Value, By Specimen, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 13 Global Immunoassay Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 14 Global Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 15 Global Immunoassay Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 16 Global Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 17 Global Immunoassay Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 18 Global Immunoassay Market Value, By Region, 2022-2031 (US$ Million)

Table 19 North America Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 20 North America Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 21 North America Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 22 North America Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 23 North America Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 24 North America Immunoassay Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Asia-Pacific Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Asia-Pacific Immunoassay Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Europe Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Europe Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 33 Europe Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 34 Europe Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 35 Europe Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 36 Europe Immunoassay Market Value, By Country, 2022-2031 (US$ Million)

Table 37 South America Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 38 South America Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 39 South America Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 40 South America Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 41 South America Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 42 South America Immunoassay Market Value, By Country, 2022-2031 (US$ Million)

Table 43 Middle East and Africa Immunoassay Market Value, By Product Type, 2022-2031 (US$ Million)

Table 44 Middle East and Africa Immunoassay Market Value, By Technology, 2022-2031 (US$ Million)

Table 45 Middle East and Africa Immunoassay Market Value, By Specimen, 2022-2031 (US$ Million)

Table 46 Middle East and Africa Immunoassay Market Value, By Application, 2022-2031 (US$ Million)

Table 47 Middle East and Africa Immunoassay Market Value, By End User, 2022-2031 (US$ Million)

Table 48 Middle East and Africa Immunoassay Market Value, By Country, 2022-2031 (US$ Million)

Table 49 Abbott: Overview

Table 50 Abbott: Product Portfolio

Table 51 Abbott: Key Developments

Table 52 Beckman Coulter, Inc: Overview

Table 53 Beckman Coulter, Inc: Product Portfolio

Table 54 Beckman Coulter, Inc: Key Developments

Table 55 F. Hoffmann-La Roche Ltd: Overview

Table 56 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 57 F. Hoffmann-La Roche Ltd: Key Developments

Table 58 Siemens Healthcare Private Limited: Overview

Table 59 Siemens Healthcare Private Limited: Product Portfolio

Table 60 Siemens Healthcare Private Limited: Key Developments

Table 61 bioM&eacute;rieux SA: Overview

Table 62 bioM&eacute;rieux SA: Product Portfolio

Table 63 bioM&eacute;rieux SA: Key Developments

Table 64 Bio-Rad Laboratories, Inc.: Overview

Table 65 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 66 Bio-Rad Laboratories, Inc.: Key Developments

Table 67 DiaSorin S.p.A.: Overview

Table 68 DiaSorin S.p.A.: Product Portfolio

Table 69 DiaSorin S.p.A.: Key Developments

Table 70 BD: Overview

Table 71 BD: Product Portfolio

Table 72 BD: Key Developments

Table 73 Thermo Fisher Scientific Inc.: Overview

Table 74 Thermo Fisher Scientific Inc.: Product Portfolio

Table 75 Thermo Fisher Scientific Inc.: Key Developments

Table 76 Merck KGaA: Overview

Table 77 Merck KGaA: Product Portfolio

Table 78 Merck KGaA: Key Developments

List of Figures

Figure 1 Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 2 Global Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 3 Global Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 4 Global Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 5 Global Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 6 Global Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 7 Global Immunoassay Market Share, By Region, 2023 &amp; 2031 (%)

Figure 8 Global Immunoassay Market Y-o-Y Growth, By Product Type, 2023-2031 (%)

Figure 9 Reagents &amp; kits Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 10 ELISA Reagents &amp; Kits Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 11 Rapid Test Reagents &amp; Kits Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 12 ELISPOT Reagents &amp; Kits&nbsp;Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 13 Western Blot Reagents &amp; Kits Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 14 Other Reagents &amp; Kits&nbsp;&nbsp; Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 15 Analyzers Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 16 Open-ended Systems Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 17 Closed-ended Systems Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 18 Software &amp; Services Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 19 Global Immunoassay Market Y-o-Y Growth, By Technology, 2023-2031 (%)

Figure 20 Radioimmunoassay (RIA) Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 21 Enzyme Immunoassay (EIA) Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 22 Fluorescence Immunoassays (FIA) Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 23 Chemiluminescence Immunoassays (CLIA) Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 24 Rapid Assays Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 25 Others Technology in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 26 Global Immunoassay Market Y-o-Y Growth, By Specimen, 2023-2031 (%)

Figure 27 Blood Specimen in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 28 Saliva Specimen in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 29 Urine Specimen in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 30 Other Specimen Specimen in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 31 Global Immunoassay Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 32 Therapeutic Drug Monitoring, Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 33 Drug Discovery Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 34 Disease Diagnosis Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 35 Infectious Disease Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 36 Cancer Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 37 Endocrinology Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 38 Autoimmune Disorders Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 39 Cardiology Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 40 Hematology Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 41 Clinical Chemistry Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 42 Others Application in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 43 Global Immunoassay Market Y-o-Y Growth, By End User, 2023-2031 (%)

Figure 44 Hospitals End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 45 Blood Banks End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 46 Clinical Laboratories End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 47 Pharmaceutical and Biotech Companies End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 48 Academic Research Centers End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 49 Others End User in Global Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 50 Global Immunoassay Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 51 North America Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 52 North America Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 53 North America Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 54 North America Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 55 North America Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 56 North America Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 57 North America Immunoassay Market Share, By Country, 2023 &amp; 2031 (%)

Figure 58 Asia-Pacific Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 59 Asia-Pacific Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 60 Asia-Pacific Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 61 Asia-Pacific Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 62 Asia-Pacific Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 63 Asia-Pacific Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 64 Asia-Pacific Immunoassay Market Share, By Country, 2023 &amp; 2031 (%)

Figure 65 Europe Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 66 Europe Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 67 Europe Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 68 Europe Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 69 Europe Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 70 Europe Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 71 Europe Immunoassay Market Share, By Country, 2023 &amp; 2031 (%)

Figure 72 South America Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 73 South America Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 74 South America Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 75 South America Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 76 South America Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 77 South America Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 78 South America Immunoassay Market Share, By Country, 2023 &amp; 2031 (%)

Figure 79 Middle East and Africa Immunoassay Market Value, 2022-2031 (US$ Million)

Figure 80 Middle East and Africa Immunoassay Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 81 Middle East and Africa Immunoassay Market Share, By Technology, 2023 &amp; 2031 (%)

Figure 82 Middle East and Africa Immunoassay Market Share, By Specimen, 2023 &amp; 2031 (%)

Figure 83 Middle East and Africa Immunoassay Market Share, By Application, 2023 &amp; 2031 (%)

Figure 84 Middle East and Africa Immunoassay Market Share, By End User, 2023 &amp; 2031 (%)

Figure 85 Abbott: Financials

Figure 86 Beckman Coulter, Inc: Financials

Figure 87 F. Hoffmann-La Roche Ltd: Financials

Figure 88 Siemens Healthcare Private Limited: Financials

Figure 89 bioM&eacute;rieux SA: Financials

Figure 90 Bio-Rad Laboratories, Inc.: Financials

Figure 91 DiaSorin S.p.A.: Financials

Figure 92 BD: Financials

Figure 93 Thermo Fisher Scientific Inc.: Financials

Figure 94 Merck KGaA: Financials

Immunoassay Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Colorimetric Immunoassays (CI) Analyzer Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2023 September 20

Starting from

Radioimmunoassay Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 02

Starting from

Chemiluminescence Immunoassay Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 11

Starting from